DLS and SLS instrument

Beskrivning

The research group of Sten Linnarsson is involved in the development and high-throughput screening of advanced cancertherapeutic products in the form of lipid nanoparticles, for which an instrument is needed to perform quality control andproduct characterization. KI intend to purchase an instrument that can measure nanoparticle size, size range composition,and absolute concentration in a highly multiplexed manner. There is only one instrument that can perform measurements of the absolute concentration of nanoparticles in a 96-, 384-, or 1536-well manner. KI has applied Voluntary ex ante transparency.